(Q39780191)

14 September 2017

1 reference

title

Spironolactone: disposition, metabolism, pharmacodynamics, and bioavailability (English)

1 reference

14 September 2017

Spironolactone: Disposition, Metabolism, Pharmacodynamics, and Bioavailability (English)

1 reference

https://api.crossref.org/works/10.3109/03602537808993782

8 April 2023

1 reference

A. Karim

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A363379

8 April 2023

language of work or name

English

0 references

publication date

1 January 1978

1 reference

full work available at URL

14 September 2017

http://www.tandfonline.com/doi/pdf/10.3109/03602537808993782

1 reference

https://api.crossref.org/works/10.3109/03602537808993782

8 April 2023

published in

Drug Metabolism Reviews

1 reference

14 September 2017

8

1 reference

14 September 2017

151-188

1 reference

14 September 2017

1

1 reference

Interactions of spironolactone with hepatic microsomal drug-metabolizing enzyme systems

14 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993782

Investigation of the effects of methyltestosterone, cortisone and spironolactone on the hepatic microsomal mixed function oxidase system in male and female rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993782

Spironolactone--a weak enzyme inducer in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993782

The Effect of Spironolactone on Antipyrine Metabolism in Man

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993782

Metabolism of digitoxin in man and its modification by spironolactone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993782

Prevention of Digitoxin Poisoning by Various Steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993782

The pharmacodynamics of single doses of prorenoate potasssium and spironolactone in fludrocortisone treated normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993782

Pharmacokinetics of spironolactone in man

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993782

Spironolactone: Diversity in Metabolic Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993782

Pharmacokinetic and Metabolic Fate of Potassium Canrenoate (SC-14266) in Man

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993782

Spironolactone and potassium canrenoate in normal man

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993782

Interference of spironolactone in 11-doexycorticosterone radioassays

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993782

Spironolactone and plasma cortisol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993782

A comparison of the use of Aldactone and Aldactone A in the treatment of hepatic ascites

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993782

Enhancement by food of canrenone bioavailability from spironolactone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993782

GLC Analysis of Hydrochlorothiazide in Blood and Plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993782

Absorption, metabolism, and excretion of hydrochlorothiazide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993782

Binding of spirolactones to human plasma proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993782

Antagonism of fludrocortisone by spironolactone and canrenone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993782

Multiple dose kinetics of spironolactone and canrenoate-potassium in cardiac and hepatic failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993782

Elimination of canrenone in congestive heart failure and chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993782

Stimulation of liver microsomal drug metabolism in male and female mice by spironolactone and aldadiene

21 January 2018

4

1 reference

https://api.crossref.org/works/10.3109/03602537808993782

Metabolism of Aniline and Hexobarbital by Liver Homogenates of Spironolactone-Pretreated Male Rats

8 April 2023

5

1 reference

https://api.crossref.org/works/10.3109/03602537808993782

The influence of spironolactone on its own biotransformation

8 April 2023

6

1 reference

https://api.crossref.org/works/10.3109/03602537808993782

Digitoxin poisoning: prevention by spironolactone

8 April 2023

15

1 reference

https://api.crossref.org/works/10.3109/03602537808993782

Increased Stool Mercury Excretion in the Rat: The Effect of Spironolactone

8 April 2023

19

1 reference

https://api.crossref.org/works/10.3109/03602537808993782

Effect of spironolactone on the distribution of mercury

8 April 2023

21

1 reference

https://api.crossref.org/works/10.3109/03602537808993782

The effects of spironolactone on the biliary excretion of mercury, cadmium, zinc, and cerium in rats

8 April 2023

22

1 reference

https://api.crossref.org/works/10.3109/03602537808993782

Relative potency of prorenoate and spironolactone in normal man

8 April 2023

24

1 reference

https://api.crossref.org/works/10.3109/03602537808993782

Isolation and identification of novel sulfur-containing metabolites of spironolactone (Aldactone®)

8 April 2023

29

1 reference

https://api.crossref.org/works/10.3109/03602537808993782

Spironolactone. I. Disposition and metabolism

8 April 2023

32

1 reference

https://api.crossref.org/works/10.3109/03602537808993782

Isolation and identification of a sulfur-containing metabolite of spironolactone from human urine

8 April 2023

33

1 reference

https://api.crossref.org/works/10.3109/03602537808993782

Prediction of Stability in Pharmaceutical Preparations XVI: Kinetics of Hydrolysis of Canrenone and Lactonization of Canrenoic Acid

8 April 2023

37

1 reference

https://api.crossref.org/works/10.3109/03602537808993782

Effect of enterohepatic circulation on the pharmacokinetics of spironolactone in man

8 April 2023

40

1 reference

https://api.crossref.org/works/10.3109/03602537808993782

On the mechanism of steroid fluorescence in sulfuric acid. Part I. The formation of trienones

8 April 2023

41

1 reference

https://api.crossref.org/works/10.3109/03602537808993782

Fluorometric Microassay for Spironolactone and Its Metabolites in Biological Fluids

8 April 2023

42

1 reference

https://api.crossref.org/works/10.3109/03602537808993782

Gas chromatographic determination of levels of aldadiene in human plasma and urine following therapeutic doses of spironolactone

8 April 2023

44

1 reference

https://api.crossref.org/works/10.3109/03602537808993782

Simple gas chromatographic method with flame ionization detection for the determination of aldadiene in human urine

8 April 2023

45

1 reference

https://api.crossref.org/works/10.3109/03602537808993782

Simultaneous automated determination of spironolactone metabolites in serum

8 April 2023

46

1 reference

https://api.crossref.org/works/10.3109/03602537808993782

Interference by Spironolactone of Radioassays for Progesterone and Estrogen

8 April 2023

49

1 reference

https://api.crossref.org/works/10.3109/03602537808993782

Conversion of spironolactone to canrenone and disposition kinetics of spironolactone and canrenoate-potassium in rats

8 April 2023

52

1 reference

https://api.crossref.org/works/10.3109/03602537808993782

Plasma Levels of Spirolactones in the Dog

8 April 2023

53

1 reference

https://api.crossref.org/works/10.3109/03602537808993782

Effect of a detergent on gastrointestinal absorption of a steroid

8 April 2023

55

1 reference

https://api.crossref.org/works/10.3109/03602537808993782

Factors Influencing Comparative Bioavailability of Spironolactone Tablets

8 April 2023

60

1 reference

https://api.crossref.org/works/10.3109/03602537808993782

8 April 2023

hospitalist physician

61

49

569

Sponer G.

1976

1 reference

https://api.crossref.org/works/10.3109/03602537808993782

Spironolactone. II. Bioavailability

8 April 2023

63

1 reference

https://api.crossref.org/works/10.3109/03602537808993782

Determination of hydrochlorothiazide in serum by high-pressure liquid chromatography

8 April 2023

68

1 reference

https://api.crossref.org/works/10.3109/03602537808993782

Spironolactone. III. Canrenone—maximum and minimum steady‐state plasma levels

8 April 2023

72

1 reference

https://api.crossref.org/works/10.3109/03602537808993782

Spironolactone and canrenoate-K: relative potency at steady state

8 April 2023

73

1 reference

https://api.crossref.org/works/10.3109/03602537808993782

Spironolactone: relationship between concentrations of dethioacetylated metabolite in human serum and milk

8 April 2023

75

1 reference

https://api.crossref.org/works/10.3109/03602537808993782

Canrenoate disposition in dogs. Tissue distribution and elimination

8 April 2023

78

1 reference

https://api.crossref.org/works/10.3109/03602537808993782

RELATIONSHIP OF PLASMA ALDADIENE LEVELS AND ANTIMINERALOCORTICOID EFFECTS OF SPIRONOLACTONE IN THE LABORATORY

8 April 2023

80

1 reference

https://api.crossref.org/works/10.3109/03602537808993782

Molecular modifications of anti-aldosterone compounds: effects on affinity of spirolactones for renal aldosterone receptors

8 April 2023

84

1 reference

https://api.crossref.org/works/10.3109/03602537808993782

Disposition kinetics of spironolactone in hepatic failure after single doses and prolonged treatment

8 April 2023

90

1 reference

https://api.crossref.org/works/10.3109/03602537808993782

8 April 2023

Identifiers

1 reference

14 September 2017

1 reference